supplement evidence

What does the evidence say about Soy Isoflavones Bone Health Meta-Analysis?

Updated October 2026

Quick Answer

Soy Isoflavones Bone Health Meta-Analysis has evidence relevant to benefits, uncertainty, and practical interpretation, but conclusions should stay close to the cited sources. One representative finding is: Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits.

Key Takeaways

  • 01Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits. [Shi Q (2026)]
  • 02Objective : This study assessed dietary soy isoflavone (SIF) intake among Chinese women ≥14 years, identified determinants, and evaluated adequacy against the Specific Proposed Level (SPL) in Chinese Dietary Reference Intakes, to inform targeted guidance. [Shi Q (2026)]
  • 03Methods : Intake was estimated using a distribution model combining 2017-2020 China National Food Consumption Survey data with SIF concentrations from food composition tables. [Shi Q (2026)]
The current Migaku evidence database contains 1 reusable source document for Soy Isoflavones Bone Health Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Conclusions : Dietary SIF intake among Chinese women ≥14 years is substantially below the SPL, a deficit that may attenuate associated health benefits. [Shi Q (2026); evidence level 3] - Objective : This study assessed dietary soy isoflavone (SIF) intake among Chinese women ≥14 years, identified determinants, and evaluated adequacy against the Specific Proposed Level (SPL) in Chinese Dietary Reference Intakes, to inform targeted guidance. [Shi Q (2026); evidence level 3] - Methods : Intake was estimated using a distribution model combining 2017-2020 China National Food Consumption Survey data with SIF concentrations from food composition tables. [Shi Q (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.

Learn next

Keep learning from this answer

GuideAshwagandha: What the Evidence Actually Says About Stress and CortisolLegacy library material — check the original sources.GuideMagnesium Glycinate benefits: what does the evidence sayLegacy library material — check the original sources.GuideProbiotics: What the Evidence Actually Supports (and What It Doesn't)Legacy library material — check the original sources.GuideL-Theanine: How It Works, What the Evidence Says, and How to Dose ItLegacy library material — check the original sources.DataSoy Isoflavones Bone Markers Randomized Trial Evidence TableLegacy library material — check the original sources.DataSoy Protein Resistance Training Randomized Trial Evidence TableLegacy library material — check the original sources.DataSoy Isoflavones Bone Turnover Meta-Analysis Evidence TableLegacy library material — check the original sources.

Sources

  1. Assessment of Dietary Soy Isoflavones Intake Among Women Aged 14 Years and Older in China: A Population-Based Cross-Sectional Study.